Wounds Australia Silver Partner Solventum marks a significant milestone in 2025: 30 years of groundbreaking advancements in wound care with V.A.C.® Therapy and skin protection with 3M™ Cavilon™ Skin Care Solutions. 

Supporting health professionals

These two pioneering product technologies are exclusively available to healthcare professionals and offer transformational approaches to wound management and skin integrity. 

V.A.C.® Therapy uses proprietary foam dressings, drapes and advanced technology to apply uniform negative pressure to the wound surface, helping to draw wound edges together, remove exudate and infectious material, and promote perfusion and granulation tissue development. 

The V.A.C.® Therapy system is the world's most researched NPWT solution and has helped to treat 10 million wounds worldwide.1 Supported by comparative clinical evidence, V.A.C.® Therapy has been shown to reduce readmission risk and minimise reoperation,2 resulting in shorter hospital stays and fewer complications.2,3 V.A.C.® Therapy has become a trusted choice for managing hard-to-heal wounds, simple and complex wounds, surgical incisions, traumatic injuries, diabetic foot ulcers, venous leg ulcers, pressure injuries, flaps, and grafts, showing a diverse multitude of use-cases that have broad applicability. 

Over the past 30 years, Cavilon™ Skin Care Solutions has developed a comprehensive range of products specifically designed to prevent skin breakdown, manage incontinence-associated dermatitis, and protect fragile skin to help patients achieve improved outcomes. 

3M™ Cavilon™ No Sting Barrier Film creates a skin protective barrier, shielding the skin from moisture and friction while allowing it to breathe. The next generation of skin care innovation is 3M™ Cavilon™ Advanced Skin Protectant that offers improved performance, quick application, and durability.4 The Cavilon™ range includes solutions to protect and create an environment that supports healing, ensuring that skin remains healthy and intact. 

Powering improved practice

For healthcare professionals, the evolution of V.A.C.® Therapy as well as Cavilon™ Skin Care Solutions have become effective medical solutions for wound management and skin care. The ease of use and versatility of these products empowers clinicians to manage complex cases with confidence. In addition, training programs and resources have been developed to provide information needed to leverage these technologies in healthcare. 

Better patient care and outcomes

Together, they offer a holistic approach to patient care. By addressing both wound healing and skin protection, healthcare professionals can provide comprehensive treatment plans tailored to individual patient needs, helping to reduce the risk of complications, enhance patient comfort, and ultimately lead to better patient outcomes. 

Solventum encourages healthcare professionals to explore these products for themselves. Find out more about V.A.C.® Therapy or explore Cavilon™ Skin Care Solutions. 

Wounds Australia Partners

This article is brought to you by Wounds Australia Silver Partner Solventum. Wounds Australia partners with industry leaders, peak bodies and other membership associations to bring the best products, research and resources to helping medical professionals deliver best practice care. Find out more about our partners. 

References: 

1. Solventum. Cumulative NPWT Wounds. 2018. 
2. Page JC, Newsander B, Schwenke DC, Hansen M, Ferguson J. Retrospective analysis of negative pressure wound therapy in open foot wounds with significant soft tissue defects. Adv Skin Wound Care. 2004;17(7):354-364. 
3. Law A L. Krebs B. Karnik B. Griffin L. Comparison of Healthcare Costs Associated With Patients Receiving Traditional Negative Pressure Wound Therapies in the Post Acute Setting. Cureus 12(11): e11790. 
4. 3M data on file. Clin-Rpt-Final-ICS-US-05-233809, Clin-Rpt-Final-ICH2-US-05-276833, and CLIN-RPT-FINAL-ICH3-US-05-305812. 

Article image: Products in Solventum's V.A.C.® Therapy and Cavilon™ Skin Care Solutions ranges.